"You are correct in they do need capital, and they themselves have stated it". Would you please point where they said this recently.
The last Qtr showed an N/A for number of quarters of funding on hand. This means they had net inflows over the quarter in the runup to the P2 start.
They also had $8.4m in cash as at 31Dec and are quite clearly well funded through well into the Phase2.
But you are right that the next raise will be with $1+.
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-24
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
82.0¢ |
Change
0.010(1.23%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 82.0¢ | 78.5¢ | $111.1K | 138.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 139 | 80.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.5¢ | 5558 | 2 |
View Market Depth
| Last trade - 15.19pm 29/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |